FLT3 and precursor B-cell acute lymphoblastic leukemia: We then determined whether FLT3 expression on primary leukemic cells correlated with other molecules reportedly involved in B-ALL disease pathophysiology or serving as targets for therapeutic approaches (Figure 1D–I; Table S1).